OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $106,164 | -40.2% | 20,145 | -68.1% | 0.00% | -42.9% |
| Q4 2022 | $177,525 | -64.1% | 63,176 | -47.0% | 0.01% | -58.8% |
| Q3 2022 | $495,000 | +489.3% | 119,265 | +603.8% | 0.02% | +466.7% |
| Q1 2022 | $84,000 | -71.0% | 16,945 | -59.2% | 0.00% | -72.7% |
| Q4 2021 | $290,000 | -19.7% | 41,541 | +15.0% | 0.01% | -15.4% |
| Q3 2021 | $361,000 | -57.5% | 36,107 | -30.2% | 0.01% | -50.0% |
| Q1 2021 | $849,000 | – | 51,726 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |